NCT03459807 - Blood Pressure Lowering in Dialysis (BOLD) Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 23, 2018

Primary Completion Date

December 6, 2018

Study Completion Date

December 6, 2018

Conditions

Blood PressureEnd Stage Renal Disease on Dialysis (Diagnosis)Chronic Kidney DiseasesChronic Kidney Disease Stage 5

Interventions

DRUG

Anti-Hypertensive medications

Use of standard Anti-Hypertensive medications

PROCEDURE

Dry Weight Adjustment

The participant's target post-dialysis dry weight is adjusted

Trial Locations (2)

UCSF, San Francisco

University of Washington, Seattle

All Listed Sponsors

collaborator

University of Washington

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of California, San Francisco

OTHER